NCT03082976View on ClinicalTrials.gov

Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

July 16, 2017

Primary Completion Date

July 24, 2019

Study Completion Date

July 24, 2019

Conditions
Ovarian Cancer
Trial Locations (1)

Unknown

Research Site, Al Ain City

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY